Isbn: 9780124046313 - Benign and Pathological Chromosomal Imbalances: Microscopic and Submicroscopic Copy Number Variations (cnvs) in Genetics and Counseling (17 results)

Hardcover. Condition: New.

Condition: New. pp. 220.

Hardcover. Condition: Brand New. 1st edition. 220 pages. 9.00x6.25x0.75 inches. In Stock.

Condition: New. pp. 220 Index 1st Edition.

Hardcover. Condition: new. Hardcover. Benign and Pathological Chromosomal Imbalances: Genetic Diagnostics, Patient Counselling, and Treatment Plan Development Clarifies the disease implications of cytogenetically visible copy number variants (CG-CNV) using cytogenetic assessment of heterochromatic or euchromatic DNA variants. This book shows how to define the inheritance and formation of (CG-CNV) using cytogenetic and molecular approaches for genetic diagnostics and treatment plan development. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.…

Hardback. Condition: New. New copy - Usually dispatched within 4 working days.

Condition: New. pp. 220.

hardcover. Condition: New. Special order direct from the distributor.

Hardcover. Condition: Brand New. 1st edition. 220 pages. 9.00x6.25x0.75 inches. In Stock.

Condition: New. Shows how to define the inheritance and formation of cytogenetically visible copy number variations using cytogenetic and molecular approaches for genetic diagnostics, patient counseling, and treatment plan development Uniquely classifies .

Condition: New. 2013. 1st Edition. hardcover. . . . . . Books ship from the US and Ireland.

Hardcover. Condition: new. Hardcover. Benign and Pathological Chromosomal Imbalances: Genetic Diagnostics, Patient Counselling, and Treatment Plan Development Clarifies the disease implications of cytogenetically visible copy number variants (CG-CNV) using cytogenetic assessment of heterochromatic or euchromatic DNA variants. This book shows how to define the inheritance and formation of (CG-CNV) using cytogenetic and molecular approaches for genetic diagnostics and treatment plan development. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.…

Condition: New. 2013. 1st Edition. hardcover. . . . . .

Condition: Used: Good. Occasion - Bon Etat - Benign & pathological chromosomal imbalances (2013) - Grand Format.

Condition: new. Questo è un articolo print on demand.

Buch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Benign & Pathological Chromosomal Imbalances systematically clarifies the disease implications of cytogenetically visible copy number variants (CG-CNV) using cytogenetic assessment of heterochromatic or euchromatic DNA variants. While variants of several megabasepair can be present in the human genome without clinical consequence, visually distinguishing these benign areas from disease implications does not always occur to practitioners accustomed to costly molecular profiling methods such as FISH, aCGH, and NGS. As technology-driven approaches like FISH and aCGH have yet to achieve the promise of universal coverage or cost efficacy to sample investigated, deep chromosome analysis and molecular cytogenetics remains relevant for technology translation, study design, and therapeutic assessment. Knowledge of the rare but recurrent rearrangements unfamiliar to practitioners saves time and money for molecular cytogeneticists and genetics counselors, helping to distinguish benign from harmful CG-CNV. It also supports them in deciding which molecular cytogenetics tools to deploy. 220 pp. Englisch.…

Buch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Benign & Pathological Chromosomal Imbalances systematically clarifies the disease implications of cytogenetically visible copy number variants (CG-CNV) using cytogenetic assessment of heterochromatic or euchromatic DNA variants. While variants of several megabasepair can be present in the human genome without clinical consequence, visually distinguishing these benign areas from disease implications does not always occur to practitioners accustomed to costly molecular profiling methods such as FISH, aCGH, and NGS. As technology-driven approaches like FISH and aCGH have yet to achieve the promise of universal coverage or cost efficacy to sample investigated, deep chromosome analysis and molecular cytogenetics remains relevant for technology translation, study design, and therapeutic assessment. Knowledge of the rare but recurrent rearrangements unfamiliar to practitioners saves time and money for molecular cytogeneticists and genetics counselors, helping to distinguish benign from harmful CG-CNV. It also supports them in deciding which molecular cytogenetics tools to deploy.…